⌘K

Home/Filings/4/0001453687-25-000036

4//SEC Filing

Brunn Carsten 4

Accession 0001453687-25-000036

CIK 0001453687other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 8:04 PM ET

Size

6.3 KB

Accession

0001453687-25-000036

Insider Transaction Report

Form 4

Period: 2025-01-03

Cartesian Therapeutics, Inc.RNAC

DirectorPresident and CEO

Transactions

Sale
Common Stock
2025-01-03$16.72/sh−8,563$143,190→ 212,804 total
Sale
Common Stock
2025-01-06$16.83/sh−8,708$146,575→ 204,096 total

Footnotes (1)

[F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

Documents

1 file

4
wk-form4_1736298292.xmlPrimary
FORM 4

Issuer

Cartesian Therapeutics, Inc.

CIK 0001453687

Entity typeother

Related Parties

1

filerCIK 0001760229

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 8:04 PM ET
Size: 6.3 KB

View on SEC.gov